Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | 1,81 € | 8,35 € | 360,97 % |
| Lexicon Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | 1,54 € | 7,66 € | 397,43 % |
| Enanta Pharmaceuticals Inc. | 6 | 4 | 0 | 0 | 12,00 € | 25,58 € | 113,15 % |
| Immunogen Inc. | 4 | 0 | 0 | 0 | 28,97 € | - | - |
| Insmed Inc. | 36 | 0 | 8 | 0 | 59,50 € | 66,18 € | 11,22 % |
| Rigel Pharmaceutical Inc. | 13 | 0 | 2 | 0 | 0,74 € | 13,82 € | 1767,20 % |
| Actinium Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | 6,71 € | 8,35 € | 24,53 % |
| Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | 5,95 € | 10,00 € | 68,07 % |
| Catalent Inc. | 1 | 0 | 0 | 0 | 52,47 € | 55,00 € | 4,82 % |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | 16,40 € | 45,10 € | 174,97 % |
| AbbVie Inc. | 43 | 0 | 22 | 0 | 153,06 € | 176,30 € | 15,18 % |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | 15,10 € | 23,00 € | 52,32 % |
| Sarepta Therapeutics | 9 | 0 | 8 | 0 | 141,35 € | 185,00 € | 30,88 % |
| Genmab A/S | 1 | 0 | 1 | 0 | 233,10 € | 250,00 € | 7,25 % |
| Acadia Pharmaceuticals | 30 | 1 | 2 | 0 | 14,93 € | 31,00 € | 107,66 % |
| MacroGenics Inc. | 13 | 0 | 0 | 0 | 3,89 € | 12,42 € | 219,40 % |
| Viatris Inc. | 3 | 0 | 2 | 0 | 9,73 € | 12,25 € | 25,87 % |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | 5,98 € | 11,05 € | 84,86 % |
| Alnylam Pharmace. | 47 | 0 | 11 | 0 | 227,60 € | 251,80 € | 10,63 % |
| Fagron N.V. | 1 | 0 | 0 | 0 | 18,24 € | 20,00 € | 9,65 % |
| TG Therapeutics Inc. | 22 | 3 | 0 | 0 | 17,08 € | 28,06 € | 64,35 % |
| Riot Blockchain Inc. | 4 | 0 | 3 | 0 | 8,70 € | 12,50 € | 43,66 % |
| Eli Lilly Corp. | 78 | 0 | 30 | 0 | 832,50 € | 895,00 € | 7,51 % |
| Sanofi S.A. ADR | 9 | 0 | 0 | 0 | 45,60 € | - | - |
| MorphoSys AG | 7 | 0 | 0 | 0 | 67,75 € | 65,00 € | -4,06 % |